B and T lymphocyte attenuator (BTLA) is another inhibitory checkpoint its upregulation is detected on both leukemic and NK cells in 46 untreated CLL patients associated with a poor prognosis. Here, BTLA is linked to B-cell chronic lymphocytic leukemia.